BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/7/2014 5:32:00 PM | Browse: 1021 | Download: 1036
Publication Name World Journal of Gastroenterology
Manuscript ID 6642
Country Japan
Received
2013-10-26 11:30
Peer-Review Started
2013-10-27 11:33
To Make the First Decision
2014-01-09 12:35
Return for Revision
2014-01-11 19:05
Revised
2014-01-25 11:44
Second Decision
2014-06-26 16:54
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-06-26 17:34
Articles in Press
2014-06-26 17:58
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2014-09-09 20:02
Publish the Manuscript Online
2014-10-07 17:32
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Short- and long-term outcome of interferon therapy for chronic hepatitis B infection
Manuscript Source Invited Manuscript
All Author List Yasushi Seo and Yoshihiko Yano
Funding Agency and Grant Number
Corresponding Author Yasushi Seo, MD, PhD, Division of Gastroenterology, Department of Internal Medicine, Kobe University Graduate School of Medicine, 7-5-1, Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. yseo@med.kobe-u.ac.jp
Key Words Chronic hepatitis B; Hepatitis B virus; Interferon ; Long-term outcome; Hepatocellular carcinoma
Core Tip The long-term ability of interferon (IFN)-? treatment of chronic hepatitis B virus (HBV) infections to prevent new cirrhosis, complications associated with cirrhosis, and development of hepatocellular carcinoma (HCC) is controversial. The beneficial effect of IFN-? treatment in reducing the development of HCC has mainly been observed in treatment responders who already have cirrhosis. These inconsistent findings may be due to the inevitable limitations of comparisons across studies, including differences in the baseline characteristics of the study and the moderate suppression of HBV replication by IFN-? relative to nucleoside/nucleotide analogs.
Publish Date 2014-10-07 17:32
Citation Seo Y, Yano Y. Short- and long-term outcome of interferon therapy for chronic hepatitis B infection. World J Gastroenterol 2014; 20(37): 13284-13292
URL http://www.wjgnet.com/1007-9327/full/v20/i37/13284.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i37.13284
Full Article (PDF) WJG-20-13284.pdf
Full Article (Word) WJG-20-13284.doc
Manuscript File 6642-Review.docx
Answering Reviewers 6642-Answering reviewers.PDF
Copyright License Agreement 6642-Copyright assignment.PDF
Non-Native Speakers of English Editing Certificate 6642-Language certificate.pdf
Peer-review Report 6642-Peer review(s).pdf
Scientific Misconduct Check 6642-CrossCheck.jpg
Scientific Editor Work List 6642-Scientific editor work list.pdf